scholarly article | Q13442814 |
P2093 | author name string | Ying Hu | |
Chunjie Zhang | |||
Cuixue Gong | |||
Xinfang Zhang | |||
P2860 | cites work | Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method | Q25938999 |
Global cancer statistics, 2012 | Q27860501 | ||
miR-18b and miR-518b Target FOXN1 during epithelial lineage differentiation in pluripotent cells | Q28117110 | ||
CCDC106 promotes non-small cell lung cancer cell proliferation | Q33688778 | ||
MiRNA as potential biomarkers and therapeutic targets for gastric cancer. | Q34036679 | ||
MiR-138 induces cell cycle arrest by targeting cyclin D3 in hepatocellular carcinoma | Q34256676 | ||
Gallic acid induces apoptosis and inhibits cell migration by upregulating miR-518b in SW1353 human chondrosarcoma cells | Q35029141 | ||
Staging system for breast cancer: revisions for the 6th edition of the AJCC Cancer Staging Manual | Q35182925 | ||
In vivo delivery of miRNAs for cancer therapy: challenges and strategies. | Q37228217 | ||
Lung Cancer Statistics | Q38669264 | ||
Lung cancer: current therapies and new targeted treatments | Q38940816 | ||
Lung cancer and miRNAs: a possible remedy for anti-metastatic, therapeutic and diagnostic applications. | Q39101386 | ||
miR-518b is down-regulated, and involved in cell proliferation and invasion by targeting Rap1b in esophageal squamous cell carcinoma | Q39283457 | ||
Dynamic plasma microRNAs are biomarkers for prognosis and early detection of recurrence in colorectal cancer | Q45065382 | ||
miR-146a and miR-146b in the diagnosis and prognosis of papillary thyroid carcinoma | Q47629674 | ||
Staging of Non-Small-Cell Lung Cancer. | Q48552563 | ||
Serum and blood based biomarkers for lung cancer screening: a systematic review. | Q50033192 | ||
MiR-186 inhibits proliferation, migration, and invasion of non-small cell lung cancer cells by downregulating Yin Yang 1. | Q50071627 | ||
Lung Cancer: Management. | Q50126364 | ||
Candidate miRNAs in human breast cancer biomarkers: a systematic review. | Q50171133 | ||
Forkhead box N1 inhibits the progression of non-small cell lung cancer and serves as a tumor suppressor. | Q54090258 | ||
Upregulated expression of miR-421 is associated with poor prognosis in non-small-cell lung cancer | Q58786028 | ||
miR-196a regulates the proliferation, invasion and migration of esophageal squamous carcinoma cells by targeting ANXA1. | Q64901256 | ||
SnapShot: non-small cell lung cancer | Q83727026 | ||
Analysis of microRNA expression profile identifies novel biomarkers for non-small cell lung cancer | Q86794359 | ||
Emerging targets in advanced non-small-cell lung cancer | Q89495039 | ||
Serum miR-191 and miR-425 as Diagnostic and Prognostic Markers of Advanced Gastric Cancer Can Predict the Sensitivity of FOLFOX Chemotherapy Regimen | Q90216839 | ||
MiR-188-5p and MiR-141-3p influence prognosis of bladder cancer and promote bladder cancer synergistically | Q90337352 | ||
MicroRNA-7-5p induces cell growth inhibition, cell cycle arrest and apoptosis by targeting PAK2 in non-small cell lung cancer | Q90519119 | ||
Characterization of hepatocellular adenoma and carcinoma using microRNA profiling and targeted gene sequencing | Q90568300 | ||
miR-650 promotes non-small cell lung cancer cell proliferation and invasion by targeting ING4 through Wnt-1/β-catenin pathway | Q90705807 | ||
miR-298 plays a pivotal role in colon cancer invasiveness by targeting PTEN | Q90763036 | ||
MiR-337-3p suppresses proliferation of epithelial ovarian cancer by targeting PIK3CA and PIK3CB | Q90822875 | ||
MiR-200a-3p promoted the malignant behaviors of ovarian cancer cells through regulating PCDH9 | Q90835206 | ||
XIST promote the proliferation and migration of non-small cell lung cancer cells via sponging miR-16 and regulating CDK8 expression | Q90838039 | ||
miR-335-5p inhibits TGF-β1-induced epithelial-mesenchymal transition in non-small cell lung cancer via ROCK1 | Q90872273 | ||
High serum miR-484 expression is associated with the diagnosis and prognosis of patients with non-small cell lung cancer | Q90886283 | ||
MiR-372-3p promotes tumor progression by targeting LATS2 in colorectal cancer | Q90916068 | ||
Upregulated miR-665 expression independently predicts poor prognosis of lung cancer and facilitates tumor cell proliferation, migration and invasion | Q91741856 | ||
Low plasma miR-25 expression is a favorite prognosis factor in non-small cell lung cancer | Q91821529 | ||
MicroRNA-16 inhibits the proliferation, migration and invasion of non-small cell lung carcinoma cells by down-regulating matrix metalloproteinase-19 expression | Q91821535 | ||
Overexpression of miR-939-3p predicts poor prognosis and promotes progression in lung cancer | Q92017767 | ||
Expressions of miR-21 and miR-210 in Breast Cancer and Their Predictive Values for Prognosis | Q92067170 | ||
Serum microRNA Signature Is Capable of Early Diagnosis for Non-Small Cell Lung Cancer | Q92276509 | ||
Association of miR-100 expression with clinicopathological features and prognosis of patients with lung cancer | Q92683787 | ||
CTCF-induced upregulation of HOXA11-AS facilitates cell proliferation and migration by targeting miR-518b/ACTN4 axis in prostate cancer | Q92873073 | ||
miR-155, miR-96 and miR-99a as potential diagnostic and prognostic tools for the clinical management of hepatocellular carcinoma | Q92890333 | ||
MiR-646 suppresses proliferation and metastasis of non-small cell lung cancer by repressing FGF2 and CCND2 | Q94456089 | ||
MicroRNA-1298-3p inhibits proliferation and invasion of glioma cells by downregulating Nidogen-1 | Q94473715 | ||
P433 | issue | 2 | |
P921 | main subject | biomarker | Q864574 |
invasion facilitation | Q112111173 | ||
P304 | page(s) | 1213-1220 | |
P577 | publication date | 2020-05-22 | |
P1433 | published in | Oncology Letters | Q20640514 |
P1476 | title | Overexpression of miR-518b in non-small cell lung cancer serves as a biomarker and facilitates tumor cell proliferation, migration and invasion | |
P478 | volume | 20 |
Search more.